Telehealth Physical Therapy for Chronic Back Pain - Ancillary Study to NCT03859713 (TeleOPT)

October 20, 2021 updated by: Julie Fritz, University of Utah

Observational Study of Telehealth Physical Therapy Provided for Persons With Chronic Low Back Pain

This study evaluated the feasibility of an 8-week physical therapy program for persons with chronic low back pain provided entirely using telehealth with real-time, interactive video sessions with a physical therapist.

Study Overview

Status

Completed

Conditions

Detailed Description

At the time of the onset of the COVID pandemic, the research team was conducting a clinical trial (the OPTIMIZE trial) investigating different nonpharmacologic treatments for persons with chronic low back pain (NCT03859713). One intervention arm in this trial is in-person physical therapy. COVID-related restrictions on in-person care prompted suspension of the OPTIMIZE trial. In order to accommodate persons in the midst of receiving treatment at the time of suspension, the study team adapted the in-person protocol for physical therapy for telehealth delivery using two-way, real-time video sessions. Because of the lack of research examining the feasibility of telehealth physical therapy provided in this manner, the study team decided to conduct a pilot study to examine the feasibility of the telehealth protocol.

This study was a prospective, longitudinal cohort of persons with chronic LBP seeking care in one of three healthcare systems; University of Utah Health and Intermountain Healthcare in Salt Lake City, Utah, and Johns Hopkins Medicine in Baltimore, Maryland. All participants were offered up to 8 weekly sessions of telehealth physical therapy. Outcomes included measures of acceptability, appropriateness, feasibility and fidelity as well as effectiveness measures including the Oswestry Disability Index and the PROMIS-29 health domains. Assessments occurred at baseline and after 10- and 26-weeks.

Study Type

Interventional

Enrollment (Actual)

126

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Baltimore, Maryland, United States, 21287
        • Johns Hopkins University
    • Utah
      • Salt Lake City, Utah, United States, 84107
        • Intermountain Health Care

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 64 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18 - 64 years at the time of enrollment.
  • Meets NIH Task Force definition of chronic LBP based on two questions: 1) How long has LBP has been an ongoing problem for you? and 2) How often has LBP been an ongoing problem for you over the past 6 months? A response of greater than 3 months to question 1, and "at least half the days in the past 6 months" to question 2 is required to satisfy the NIH definition of chronic LBP.
  • Healthcare visit for LBP in the past 90 days.
  • At least moderate levels of pain and disability requiring ODI score >24 and pain intensity rating > 4.

Exclusion Criteria:

  • Evidence of serious pathology as a cause of LBP including neoplasm, inflammatory disease (e.g., ankylosing spondylitis), vertebral osteomyelitis, etc.
  • Evidence of a specific spinal pathology as the cause of LBP including spine fracture, spinal stenosis, radiculopathy, etc.
  • Knowingly pregnant
  • Unable to participate in telehealth due to lack of technology or internet access
  • Has received physical therapy for LBP in prior 90 days
  • Currently receiving substance use disorder treatment
  • Any lumbar spine surgery in the past year.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Telehealth Physical Therapy
Weekly sessions of education, advice and exercise instruction provided by a licensed physical therapist using real-time, interactive video conferencing platform.
Weekly sessions of physical therapy provided using two-way, interactive, video technology consisting of education, advice and exercise instruction.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant Satisfaction with Telehealth Treatment
Time Frame: 10-weeks
Survey of participants evaluating treatment satisfaction
10-weeks
Rate of refusal to participate
Time Frame: Baseline
Ratio of persons entering the study among all those eligibility for enrollment
Baseline
Rate of enrolled participants initiating telehealth treatment
Time Frame: 10-weeks
Ratio of persons attending at least 1 treatment session among all those enrolled
10-weeks
Number of sessions
Time Frame: 10-weeks
Number of telehealth physical therapy sessions attended
10-weeks
Change in Oswestry from baseline to 10-weeks
Time Frame: baseline, 10 weeks
10 item measure of back pain-related disability
baseline, 10 weeks
Change in Oswestry from baseline to 26-weeks
Time Frame: baseline, 26 weeks
10 item measure of back pain-related disability
baseline, 26 weeks
Change in Pain Interference from baseline to 10 weeks
Time Frame: baseline, 10 weeks
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
baseline, 10 weeks
Change in Pain Interference from baseline to 26 weeks
Time Frame: baseline, 26 weeks
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
baseline, 26 weeks
Change in Pain Intensity from baseline to 10 weeks
Time Frame: baseline, 10 weeks
PROMIS single item (part of PROMIS-29) assessing pain intensity on 0-10 rating scale
baseline, 10 weeks
Change in Pain Intensity from baseline to 26 weeks
Time Frame: baseline, 26 weeks
PROMIS single item (part of PROMIS-29) assessing pain intensity on 0-10 rating scale
baseline, 26 weeks
Change in Fatigue from baseline to 10 weeks
Time Frame: baseline, 10 weeks
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
baseline, 10 weeks
Change in Fatigue from baseline to 26 weeks
Time Frame: baseline, 26 weeks
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
baseline, 26 weeks
Change in Sleep Disturbance from baseline to 10 weeks
Time Frame: baseline, 10 weeks
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
baseline, 10 weeks
Change in Sleep Disturbance from baseline to 26 weeks
Time Frame: baseline, 26 weeks
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
baseline, 26 weeks
Change in Anxiety from baseline to 10 weeks
Time Frame: baseline, 10 weeks
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
baseline, 10 weeks
Change in Anxiety from baseline to 26 weeks
Time Frame: baseline, 26 weeks
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
baseline, 26 weeks
Change in Depression from baseline to 10 weeks
Time Frame: baseline, 10 weeks
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
baseline, 10 weeks
Change in Depression from baseline to 26 weeks
Time Frame: baseline, 26 weeks
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
baseline, 26 weeks
Change in Social Role Participation from baseline to 10 weeks
Time Frame: baseline, 10 weeks
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
baseline, 10 weeks
Change in Social Role Participation from baseline to 26 weeks
Time Frame: baseline, 26 weeks
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
baseline, 26 weeks
Change in Physical Function from baseline to 10 weeks
Time Frame: baseline, 10 weeks
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
baseline, 10 weeks
Change in Physical Function from baseline to 26 weeks
Time Frame: baseline, 26 weeks
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
baseline, 26 weeks
Change in Pain Self-Efficacy Scale from baseline to 10 weeks
Time Frame: baseline, 10 weeks
10-item measure of confidence in performing activities even with pain
baseline, 10 weeks
Change in Pain Self-Efficacy Scale from baseline to 26 weeks
Time Frame: baseline, 26 weeks
10-item measure of confidence in performing activities even with pain
baseline, 26 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Julie Fritz, PT, PhD, University of Utah

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 18, 2020

Primary Completion (Actual)

December 18, 2020

Study Completion (Actual)

August 13, 2021

Study Registration Dates

First Submitted

October 11, 2021

First Submitted That Met QC Criteria

October 20, 2021

First Posted (Actual)

November 2, 2021

Study Record Updates

Last Update Posted (Actual)

November 2, 2021

Last Update Submitted That Met QC Criteria

October 20, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB_00116150

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Telehealth Physical Therapy

Subscribe